Denali Therapeutics Inc. (FRA:4DN)
Germany
· Delayed Price · Currency is EUR 17.19
+1.00 (6.18%)
Last updated: Dec 5, 2025, 8:16 AM CET
Denali Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -498.74 | -422.77 | -145.22 | -325.99 | -290.58 | 71.14 | Upgrade
|
| Depreciation & Amortization | 5.75 | 1.09 | 16.73 | 10.38 | 8.59 | 8.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -14.54 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 7.9 | 7.9 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -14.78 | -35.12 | -43.95 | -1.64 | 8.75 | 0.06 | Upgrade
|
| Stock-Based Compensation | 100.76 | 102.88 | 108.1 | 99.85 | 85.25 | 50.35 | Upgrade
|
| Other Operating Activities | -4.35 | -4.07 | -3.72 | -3.29 | -2.98 | -2.32 | Upgrade
|
| Change in Accounts Payable | -2.83 | 1.44 | 2.43 | 2.27 | 3.71 | -1.62 | Upgrade
|
| Change in Unearned Revenue | - | - | -290.53 | -34.46 | -15.66 | 278.17 | Upgrade
|
| Change in Other Net Operating Assets | 8.51 | 15.5 | -1.83 | 8.16 | -8.46 | 11.86 | Upgrade
|
| Operating Cash Flow | -397.78 | -347.69 | -357.99 | -244.72 | -211.39 | 416.15 | Upgrade
|
| Capital Expenditures | -13.07 | -15.91 | -12.94 | -17.83 | -8.5 | -3.1 | Upgrade
|
| Investment in Securities | 419.79 | -72.84 | 262.25 | -123.55 | -13.13 | -620.11 | Upgrade
|
| Investing Cash Flow | 406.72 | -88.76 | 249.31 | -141.39 | -21.63 | -623.21 | Upgrade
|
| Long-Term Debt Repaid | - | -32.34 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -16.48 | -32.34 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | 9.39 | 517.12 | 17.82 | 311.73 | 19.35 | 634.75 | Upgrade
|
| Other Financing Activities | - | -0.48 | - | -1.06 | - | - | Upgrade
|
| Financing Cash Flow | -7.09 | 484.3 | 17.82 | 310.67 | 19.35 | 634.75 | Upgrade
|
| Net Cash Flow | 1.86 | 47.85 | -90.86 | -75.43 | -213.67 | 427.7 | Upgrade
|
| Free Cash Flow | -410.85 | -363.61 | -370.93 | -262.55 | -219.89 | 413.06 | Upgrade
|
| Free Cash Flow Margin | - | - | -112.22% | -242.06% | -451.88% | 123.06% | Upgrade
|
| Free Cash Flow Per Share | -2.40 | -2.21 | -2.70 | -2.09 | -1.81 | 3.67 | Upgrade
|
| Cash Interest Paid | 0.3 | 0.3 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | - | 0 | 0.05 | 0.21 | - | Upgrade
|
| Levered Free Cash Flow | -249.6 | -208.83 | -290.45 | -141.03 | 200.41 | 109.03 | Upgrade
|
| Unlevered Free Cash Flow | -249.16 | -208.64 | -290.45 | -141.03 | 200.41 | 109.03 | Upgrade
|
| Change in Working Capital | 5.69 | 16.94 | -289.93 | -24.03 | -20.41 | 288.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.